Infection requiring systemic antibiotic therapy or other serious infection within 14 days before registration
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Patients who have an infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment are not eligible
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring intravenous antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring intravenous (IV) antibiotic therapy or other serious infection within 14 days before randomization.
Systemic infection requiring intravenous (IV) antibiotic or antifungal or antiviral therapy within 7 days preceding the first dose of study drug, or other severe infection
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study drug administration
Infection requiring systemic intravenous antibiotic therapy or other serious infection within 14 days before study enrollment
Serious infection requiring parenteral antibiotic therapy or any other serious infection within 14 days before randomization.
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Systemic infection requiring intravenous (IV) antibiotic therapy =< 14 days prior to registration
Systemic infection requiring intravenous (IV) antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days prior to start of study treatment
Infection requiring systemic IV antibiotic therapy within 7 days before cycle 1 day 1 of therapy
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Systemic infection requiring intravenous (IV) antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment.
Infection requiring systemic antibiotic therapy within 14 days prior to the start of study treatment
Infection requiring systemic antibiotic therapy or other serious infection ? 7 days prior to registration
Systemic infection requiring IV antibiotic therapy within 7 days preceding the first dose of study drug, or other severe infection
Systemic infection requiring intravenous (IV) antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before first dose of study drug
Serious infection requiring systemic antibiotic therapy within 14 days prior to study treatment.
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Systemic infection requiring IV antibiotic therapy within 7 days preceding the first dose of study drug, or other severe infection
Systemic infection requiring intravenous (IV) antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Infection requiring intravenous (IV) antibiotic therapy or other serious infection within 14 days before randomization.
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within 7 days prior to the first dose of study treatment.
Active clinically serious infection > Common Terminology Criteria for Adverse Events (CTCAE) grade 2 or systemic infection requiring IV antibiotic therapy within 14 days preceding the first dose of study drug
Active clinically serious infection > Common Terminology Criteria for Adverse Events (CTCAE) grade 2 or systemic infection requiring IV antibiotic therapy within 14 days preceding the first dose of study drug
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before randomization.
Systemic infection requiring IV antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Subject has systemic infection requiring intravenous (IV) antibiotic therapy within 7 days preceding the first dose of study drug, or other severe infection
Serious infection requiring intravenous antibiotic therapy within 14 days prior to study treatment
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within 7 days prior to the first dose of study treatment.
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within 7 days prior to the first dose of study treatment.
Infection requiring IV antibiotic therapy or other serious infection within 14 days prior to first dose of study drug
Systemic infection requiring IV antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within 7 days prior to the first dose of study treatment. For the HCC, HCC/BTC and BTC subgroups hepatitis C infection and hepatitis B infection if controlled with antiviral therapy are allowable.
Systemic infection requiring intravenous (IV) antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection
Systemic infection requiring parenteral antibiotic therapy or other serious infection (bacterial, fungal, or viral) within 21 days before the first dose of study drug.
Systemic infection requiring IV antibiotic therapy or other serious infection within 14 days before the first dose of study drug.
Infection requiring systemic antibiotic therapy within 14 days prior to start of study treatment
Infection requiring systemic antibiotic therapy or other serious infection within 14 days before study enrollment
Systemic infection requiring intravenous antibiotic therapy or other serious infection within 14 days before the first dose of study drug.
